Print

Insulin Plus Growth Factor Inhibitor Limits Vision Damage in Diabetic Mice, Cleveland Clinic Study  
12/18/2012 7:25:51 AM

A new therapeutic approach to diabetes that combines insulin and an inhibitor of the epidermal growth factor (EGF) betacellulin could limit the progression of diabetic macular edema (DME), Cleveland Clinic researcher Bela Anand-Apte, MD, PhD, said at the American Society for Cell Biology Annual Meeting, on Dec. 17 in San Francisco.
//-->